不孕及不孕治疗对早孕期胎盘DNA甲基化和基因表达影响甚微
本研究比较自然受孕、非体外受精助孕和体外受精助孕的早孕期胎盘DNA甲基化,发现显著差异的CpG位点极少,且这些位点未导致校正后显著的基因表达改变。结论认为潜在不孕而非具体助孕方式是胎盘甲基化微小差异的最主要来源。
要点
- 在741145个探针中,助孕受孕与自然受孕相比仅185个CpG位点显著(0.025%)。
- 体外受精与非体外受精助孕相比仅13个CpG位点显著(0.0018%)。
- 显著CpG位点中10%(35个)所在基因有提示性表达改变,但校正后均不显著。
核心结论
- 潜在不孕是早孕期胎盘甲基化微小差异的最主要决定因素,而非所采用的具体助孕方式如体外受精。
研究设计与样本
- 学术医疗中心研究,对138例经绒毛膜绒毛取样并活产的單胎妊娠胎盘进行DNA甲基化分析(56例自然受孕、38例非体外受精助孕、44例体外受精受孕)。
- RNA测序数据包括141例受试者(74例自然受孕、33例非体外受精助孕、34例体外受精受孕),其中116例与甲基化队列重叠。
- 使用Infinium MethylationEPIC BeadChip阵列比较三组胎盘DNA甲基化,并将显著CpG位点与相似队列的RNA测序分析比较以确定甲基化改变是否导致基因表达差异。
主要发现
- 在741145个探针中,Bonferroni<0.05显著的位点:助孕受孕(非体外受精+体外受精)vs自然受孕为185个CpG位点(0.025%)。
- 非体外受精助孕vs自然受孕为28个CpG位点显著;体外受精vs自然受孕为195个CpG位点显著。
- 体外受精vs非体外受精助孕仅13个CpG位点显著(0.0018%)。
- 所有显著CpG位点合计中,10%(35个)位于有提示性基因表达改变的基因,但校正多重比较后均不显著(RNA测序错误发现率<0.05)。
- 体外受精vs非体外受精胎盘中13个差异甲基化探针所在基因均无提示性表达差异。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether deoxyribonucleic acid (DNA) methylation alterations exist in the first-trimester human placenta between conceptions using fertility treatments and those that do not and, if so, whether they are the result of underlying infertility or fertility treatments. We also assessed whether significant alterations led to changes in gene expression. DESIGN: We compared DNA methylation of the first-trimester placenta from singleton pregnancies that resulted in live births from unassisted, in vitro fertilization (IVF), and non-IVF fertility treatment (NIFT) conceptions using the Infinium MethylationEPIC BeadChip array. Significant CpG sites were compared with corresponding ribonucleic acid sequencing analysis in similar cohorts to determine whether methylation alterations lead to differences in gene expression. SETTING: Academic medical center. PATIENT(S): A total of 138 singleton pregnancies undergoing chorionic villus sampling resulting in a live birth were recruited for methylation analysis (56 unassisted, 38 NIFT, and 44 IVF conceptions). Ribonucleic acid-sequencing data consisted of 141 subjects (74 unassisted, 33 NIFT, and 34 IVF conceptions) of which 116 overlapped with the methylation cohort. INTERVENTION(S): In vitro fertilization-conceived pregnancy or pregnancy conceived via NIFT, such as ovulation induction and intrauterine insemination. MAIN OUTCOME MEASURE(S): Significant methylation changes at CpG sites after adjustment for multiple comparisons. The secondary outcome was gene expression changes of significant CpG sites. RESULT(S): Of the 741,145 probes analyzed in the placenta, few were significant at Bonferroni <0.05: 185 CpG sites (0.025%) significant in pregnancies conceived with the fertility treatments (NIFT + IVF) vs. unassisted conceptions; 28 in NIFT vs. unassisted; 195 in IVF vs. unassisted; and only 13 (0.0018%) in IVF vs. NIFT conceptions. Of all significant CpG sites combined, 10% (35) were located in genes with suggestive gene expression changes, but none were significant after adjustment for multiple comparisons (ribonucleic acid sequencing false discovery rate <0.05). None of the 13 differentially methylated probes in the IVF vs. NIFT placenta were located in genes with suggestive IVF vs. NIFT gene expression differences. CONCLUSION(S): Underlying infertility is the most significant contributor to the minimal differences in first-trimester placental methylation, and not the specific fertility treatment used, such as IVF.
引用
- Gonzalez TL, Schaub AM, Lee B, et al. Infertility and treatments used have minimal effects on first-trimester placental DNA methylation and gene expression. Fertil Steril. 2022. PMID: 36379261. doi:10.1016/j.fertnstert.2022.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。